Resverlogix

TSX:RVX
RVXCF
Request Investor Info

Resverlogix is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses and providing value-based health solutions to key partners.

Projects
Stories
Presentation
Contact
Management
Financials
Resverlogix Stock Price Today
Resverlogix Fundamental Data by TradingView

Company Feed

Resverlogix
December 15, 2021

FOX - Resverlogix: Dedicated to Improving the Lives of Patients with Chronic Illnesses

Resverlogix is committed to developing epigenetic therapies for the benefit of patients with chronic disease. Their current clinical program focuses o …

This is some text inside of a div block.
Resverlogix
October 4, 2021

Resverlogix: The Future of Drug Development

Resverlogix is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses and providing value-bas …

This is some text inside of a div block.
Subscribe and receive the investor Info